Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
Qi Fei(Novartis (China)), Jianyong Shou(Novartis (Switzerland)), Yuan Zhao(Novartis (China)), Desheng Kong(Eye & ENT Hospital of Fudan University), Shannon Chuai(Novartis (China)), Tianlun Zhou(Fox Chase Cancer Center), Peter Atadja(University of Health and Allied Sciences), Jidong Zhu(Regend Therapeutics (China)), Xing Feng(Rutgers, The State University of New Jersey), Shijun Fu(Novartis (China)), Zhi‐Xiong Jim Xiao(Ministry of Education of the People's Republic of China), Zhui Chen(Novartis (China)), Zheng Huang(Sun Yat-sen University), Ying Liang(BGI Group (China)), Ke Shang(Tongji Hospital), Yun Zhang(Guilin University of Technology), Chong Li(Fudan University), Jianhua Zhang(XinHua Hospital), Zhi Chen(Fujian Agriculture and Forestry University), Haiyan Xu(Tongji University), Min Hu(Jilin University), En Li(Chongqing University), Zhengtian Yu(Novartis (China)), Haiyan Ying(University of Chicago), Chuang Lu, Kehao Zhao(Novartis (China))
Cited by 171
Related Papers
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
|Clinical Infectious Diseases|2020|5k
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
|Nature|2000|3.3k
CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting
|Nucleic Acids Research|2022|1.9k
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
|SSRN Electronic Journal|2020|963